Five years on, patent fund IP Bridge is not only surviving, but beginning to thrive. It is a symbol of a slowly cha… https://t.co/Mlh6v3XlMF
A CAFC judgment that slammed RPX could turn out to be very bad news for Unified Patents. https://t.co/0loRDtA2hg
CAFC decision puts third party IPR filing strategies in the spotlight and could spell trouble for the likes of RPX… https://t.co/WeMpfsWNvP
Recently, I attended a reception in Tokyo to celebrate the fifth anniversary of Japanese patent fund IP Bridge. The occasion brought out a mix of guests from industry, investment and government. On hand were executives from operating companies including Panasonic, NEC, Hitachi, Seiko Epson, Fujitsu, NTT Docomo, Canon and KDDI. Finance was also well represented, with representatives from the...
The ability of the likes of RPX and Unified Patents to file inter partes reviews (IPRs) against patents that have been asserted against their members in district court has been called into question by a recent decision from the Court of Appeals for the Federal Circuit (CAFC). In the case, RPX filed an IPR against two patents owned by the NPE Applications in Internet Time. Those grants...
Unless the United States takes action now to improve its innovation and commercialisation processes, it will lose its leading position by all measures of innovation by 2029, the authors of a new report have claimed. The outlook is similarly gloomy for the EU and the UK, with the study predicting that East Asian countries – mainly China and South Korea – are set to race past their...
Greater licensing of their secondary patents would not only generate additional income for many pharma companies but would also enable the industry to serve patients better and avoid political controversy